Collectively, these results demonstrate that the combination of ATO and Dasatinib synergistically induces cell apoptosis in Ph+ ALL cell lines both by activating the IRE1‐JNK‐PUMA apoptosis pathway and abolishing the ATF4‐induced cell survival pathway. This evidence concerns the gene MAPK8 and acute lymphoblastic leukemia.